Gene Mutation Can Raise Risk of Alcohol and Drug Abuse
An interplay between genetic and early environmental factors contributes to the development of substance abuse.
What Psychiatrists Think About Artificial Intelligence
Results of the first global survey of psychiatrists on the impact of future autonomous technology.
New Drug Application for Olanzapine/Samidorphan Expanded to Include Bipolar I
The novel combination drug is designed to mitigate the weight gain associated with olanzapine.
New Treatment Reduces Levels of Protein Linked to Huntington Disease
The first therapy to target the primary mechanism of the disease is safe and well tolerated, say study investigators.
Work Stress Takes a Toll on Physicians’ Health
The fallout from burnout: alcohol dependence, binge eating, sleep disorders, and general ill health.
Newly Identified Neural Circuit May Be Target for Future PTSD Treatments
Recent findings could pave the way for targeted therapies for conditions associated with hypervigilance and recurrent distressing memories.
Brain Stimulation for Cognitive Deficits in Schizophrenia
A novel neuromodulatory intervention for an often-overlooked but nonetheless damaging effect of schizophrenia.
2 Clarke Drive Cranbury, NJ 08512